Metraipolis › archive › dc_6ea3bbc50022

Access to Orphan Medicinal Products in Bulgaria: An Analysis of the Positive Drug List and Individual Access Schemes — Europe PMC PMID:41008390

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41008390
DOI
10.3390/healthcare13182258
License (as archived)
solo-consultazione
Archived
2026-11-10T01:41:34.639Z
SHA-256 of the archived text
ad177cd236f712e24852bd2db6aa4a7d13e5f407df9075ba78b364aa42800e72
Stable URL of this page
https://metraipolis.com/documento/dc_6ea3bbc50022

How to cite

Access to Orphan Medicinal Products in Bulgaria: An Analysis of the Positive Drug List and Individual Access Schemes — Europe PMC PMID:41008390 — Europe PMC (en), https://europepmc.org/article/MED/41008390 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ea3bbc50022 (Metraipolis archive dc_6ea3bbc50022, sha256 ad177cd236f712e24852bd2db6aa4a7d13e5f407df9075ba78b364aa42800e72)
BibTeX
@misc{dc6ea3bbc50022,
  title = {Access to Orphan Medicinal Products in Bulgaria: An Analysis of the Positive Drug List and Individual Access Schemes — Europe PMC PMID:41008390},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008390},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ea3bbc50022; sha256 ad177cd236f712e24852bd2db6aa4a7d13e5f407df9075ba78b364aa42800e72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008390. Agents can read the archived copy with the MCP tool read_document.